{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T15:33:29Z","timestamp":1782228809086,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.beem.2023.101837","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T22:05:02Z","timestamp":1698789902000},"page":"101837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Phosphate: An underrated component of primary hyperparathyroidism"],"prefix":"10.1016","volume":"38","author":[{"given":"Sanjay Kumar","family":"Bhadada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaditya","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimesh","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soham","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2023.101837_bib1","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101837_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7617254","article-title":"Symptomatic hypercalcemia in patients with primary hyperparathyroidism is associated with severity of disease, polypharmacy, and comorbidity","volume":"2019","author":"Aresta","year":"2019","journal-title":"Int J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101837_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Min Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101837_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00774-020-01142-w","article-title":"Progressive rise in the prevalence of asymptomatic primary hyperparathyroidism in India: data from PHPT registry","volume":"39","author":"Arya","year":"2021","journal-title":"J Bone Min Metab"},{"key":"10.1016\/j.beem.2023.101837_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coph.2015.03.005","article-title":"Parathyroid hormone: anabolic and catabolic actions on the skeleton","volume":"22","author":"Silva","year":"2015","journal-title":"Curr Opin Pharm"},{"issue":"7","key":"10.1016\/j.beem.2023.101837_bib6","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101837_bib7","unstructured":"Lee K., Brown D., Urena P., et al. Localization of parathyroid hormone\/parathyroid hormone-related peptide receptor mRNA in kidney."},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1981.tb15505.x","article-title":"Actions of parathyroid hormone on isolated renal tubules","volume":"372","author":"Dennis","year":"1981","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.beem.2023.101837_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/jcm10081604","article-title":"Primary hyperparathyroidism: a narrative review of diagnosis and medical management","volume":"10","author":"Dandurand","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.beem.2023.101837_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/cen.14915","article-title":"Characterization of primary hyperparathyroidism based on target organ involvement: an analysis from the Indian PHPT registry","author":"Mukherjee","year":"2023","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2023.101837_bib11","first-page":"14","article-title":"Large parathyroid adenomas: potential mechanisms to reconcile adenoma size and disease phenotype","author":"Bhan","year":"2023","journal-title":"Front Endocrinol)"},{"issue":"8","key":"10.1016\/j.beem.2023.101837_bib12","first-page":"1895","article-title":"Bone and mineral metabolism phenotypes in MEN1-related and sporadic primary hyperparathyroidism, before and after parathyroidectomy","volume":"10","author":"Marini","year":"2021","journal-title":"Cells 2021"},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","article-title":"Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism","volume":"151","author":"Yamashita","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101837_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s12020-020-02276-7","article-title":"The calcium-to-phosphorous (Ca\/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study","volume":"68","author":"Madeo","year":"2020","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.beem.2023.101837_bib15","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/jc.2011-0569","article-title":"Mosekilde L. nephrolithiasis and renal calcifications in primary hyperparathyroidism","volume":"96","author":"Rejnmark","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2023.101837_bib16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40618-020-01441-z","article-title":"Primary hyperparathyroidism in pregnancy: observations from the Indian PHPT registry","volume":"44","author":"Pal","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"10.1016\/j.beem.2023.101837_bib17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF03349939","article-title":"Primary hyperparathyroidism: changes on biochemical and hormonal profile related to pregnancy","volume":"12","author":"Lopez","year":"1989","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.beem.2023.101837_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/cc9215","article-title":"Treatment of hypophosphatemia in the intensive care unit: a review","volume":"14","author":"Geerse","year":"2010","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.beem.2023.101837_bib19","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0026-0495(76)90124-4","article-title":"The actions of parathyroid hormone on bone: relation to bone remodeling and turnover, calcium homeostasis, and metabolic bone diseases. II. PTH and bone cells: bone turnover and plasma calcium regulation","volume":"25","author":"Parfitt","year":"1976","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.beem.2023.101837_bib20","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2016-1513","article-title":"Forearm DXA increases the rate of patients with asymptomatic primary hyperparathyroidism meeting surgical criteria","volume":"101","author":"Castellano","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101837_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00240-007-0096-2","article-title":"Biochemical characterization of primary hyperparathyroidism with and without kidney stones","volume":"35","author":"Odvina","year":"2007","journal-title":"Urol Res"},{"issue":"6","key":"10.1016\/j.beem.2023.101837_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0039-6060(96)80051-1","article-title":"Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones","volume":"120","author":"Soreide","year":"1996","journal-title":"Surgery"},{"issue":"10","key":"10.1016\/j.beem.2023.101837_bib23","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the fourth international workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101837_bib24","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1210\/clinem\/dgab676","article-title":"Phosphate: a neglected test in the clinical management of primary hyperparathyroidism","volume":"107","author":"Castellano","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2023.101837_bib25","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-023-02064-w","article-title":"The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism","author":"D\u00fc\u011fer","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.beem.2023.101837_bib26","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/jbmr.1846","article-title":"Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice","volume":"28","author":"Cheng","year":"2013","journal-title":"J Bone Min Res"},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib27","article-title":"Isolated hypophosphataemia as an early marker of primary hyperparathyroidism","volume":"2021","author":"Alexander","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"8","key":"10.1016\/j.beem.2023.101837_bib28","article-title":"The impact of moderate hypophosphatemia on the clinical management of primary hyperparathyroidism","volume":"15","author":"G\u00fcne\u015f","year":"2023","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ando.2022.10.015","article-title":"Spectrum of renal dysfunction after curative parathyroidectomy in symptomatic primary hyperparathyroidism","volume":"84","author":"Gosavi","year":"2023","journal-title":"Ann Endocrinol"},{"issue":"9","key":"10.1016\/j.beem.2023.101837_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4158\/EP.14.9.1133","article-title":"Distal renal tubular acidosis due to primary hyperparathyroidism","volume":"14","author":"Muthukrishnan","year":"2008","journal-title":"Endocr Pr"},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.surg.2018.04.088","article-title":"End-organ effects of primary hyperparathyroidism: a population-based study","volume":"165","author":"Assadipour","year":"2019","journal-title":"Surg"},{"issue":"3","key":"10.1016\/j.beem.2023.101837_bib32","first-page":"136","article-title":"Hypophosphatemia: an evidence-based approach to its clinical consequences and management","volume":"2","author":"Amanzadeh","year":"2006","journal-title":"Nat Clin Pr Nephrol 2006 23"},{"issue":"3","key":"10.1016\/j.beem.2023.101837_bib33","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0889-8529(05)70149-3","article-title":"Medical approaches to primary hyperparathyroidism","volume":"29","author":"Strewler","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.beem.2023.101837_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/00015458.2006.11679946","article-title":"The effects of successful parathyroidectomy on clinical and biological manifestations of primary hyperparathyroidism","volume":"106","author":"P\u00e9rez-Ruiz","year":"2016","journal-title":"Acta Chir Belg."},{"issue":"7","key":"10.1016\/j.beem.2023.101837_bib35","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1210\/jc.2003-030908","article-title":"Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial","volume":"89","author":"Khan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1359\/jbmr.2001.16.1.113","article-title":"Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism","volume":"16","author":"Rossini","year":"2001","journal-title":"J Bone Min Res"},{"issue":"2","key":"10.1016\/j.beem.2023.101837_bib37","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/jc.2002-020890","article-title":"Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism","volume":"88","author":"Chow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101837_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00774-013-0473-6","article-title":"Effect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism","volume":"32","author":"Tournis","year":"2014","journal-title":"J Bone Min Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101837_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2023.101837_bib40","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101837_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-011-9459-0","article-title":"Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism","volume":"39","author":"Faggiano","year":"2011","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.beem.2023.101837_bib42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","article-title":"Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Leere","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101837_bib43","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/EJE-12-0528","article-title":"Therapy of endocrine disease: hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature","volume":"168","author":"Witteveen","year":"2013","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:57Z","timestamp":1761497997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1521690X23001112"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101837","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphate: An underrated component of primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101837","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101837"}}